glp-1 obesity injector components New Guidelines on Drugs for Released Weighty issue: GLP-1 drugs are

Some patients may experience genuine physiological hunger, whilst others may be responding to habitual eating cues, thirst misinterpreted as hunger, or psychological factors

These medications have seen an explosion in sales with the approval and off-label use for weight loss, typically resulting in a reduction in body weight of 15-21% when combined with nutrition and exercise

Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index

Neuropsychopharmacology 31 , 12031211 (2006)

Use a protein calculator to find your personal target based on body weight

But research protocols sometimes call for non-standard doses